Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
January-2021 Volume 21 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-2021 Volume 21 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Effects of matrine in combination with cisplatin on liver cancer

  • Authors:
    • Gaoyu Hu
    • Cong Cao
    • Zhihua Deng
    • Jun Li
    • Xihan Zhou
    • Zansong Huang
    • Chao Cen
  • View Affiliations / Copyright

    Affiliations: Department of Gastroenterology, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi 533000, P.R. China, Department of General Medicine, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi 533000, P.R. China
    Copyright: © Hu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 66
    |
    Published online on: November 25, 2020
       https://doi.org/10.3892/ol.2020.12327
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Matrine, an alkaloid isolated from Sophora flavescens, promotes tumor cell apoptosis and strengthens the anticancer capacity of chemotherapeutic drugs. The present study aimed to investigate the inhibitory effect and underlying mechanism of matrine in combination with cisplatin on liver cancer progression. Tumor progression was studied in nude mice. The human liver cancer cell line HepG2 was injected into BALB/c nude mice subcutaneously to establish a tumor model. Mice were subsequently treated with matrine, cisplatin, matrine + cisplatin or normal saline. Nude mice and tumor growth were monitored. Tumors were excised and the expression of survivin, caspase-3, caspase-7 and caspase-9 was detected by immunohistochemistry. Western blotting was used to determine the expression of survivin, caspase-3, caspase-7, caspase-9 and X‑linked inhibitor of apoptosis protein (XIAP) in tumor tissues. The results demonstrated that matrine exerted anticancer effects in liver cancer‑transplanted tumors, as evidenced by decrease in tumor weight and volume. Furthermore, the tumor inhibition rate in mice treated with matrine + cisplatin was 83.3%, whereas it was of 37.5 and 75% in mice treated with matrine or cisplatin alone, respectively. In addition, the expression of survivin and XIAP was significantly downregulated, whereas the expression of caspase-3, caspase-7 and caspase-9 was significantly upregulated in tumor tissues from nude mice treated with matrine + cisplatin, compared with those treated with cisplatin, matrine or normal saline. These findings suggested that the combination of matrine and cisplatin may promote tumor cell apoptosis in liver cancer by activating the caspase apoptosis pathway and suppressing the survivin‑associated inhibition of caspase‑9.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI

2 

Chan SL and Yeo W: Development of systemic therapy for hepatocellular carcinoma at 2013: Updates and insights. World J Gastroenterol. 20:3135–3145. 2014. View Article : Google Scholar : PubMed/NCBI

3 

Wei YP, Shen NJ, Wang ZC, Yang GS, Yi B, Yang N, Qiu YH and Lu JH: Sorafenib sensitizes hepatocellular carcinoma cell to cisplatin via suppression of Wnt/β-catenin signaling. Mol Cell Biochem. 381:139–144. 2013. View Article : Google Scholar : PubMed/NCBI

4 

Jung SH, Kim HJ, Oh GS, Shen A, Lee S, Choe SK, Park R and So HS: Capsaicin ameliorates cisplatin-induced renal injury through induction of heme oxygenase-1. Mol Cells. 37:234–240. 2014. View Article : Google Scholar : PubMed/NCBI

5 

Jin J, Ye MC, Wang LP, Li RX, Zhou Y, Wang Y, Zhu WZ, Zuo Y and Liu SH: Grade IV Myelosuppression after induction chemotherapy of TPF on oral cancer: Clinical analysis of 29 cases. Shanghai Kou Qiang Yi Xue. 23:219–223. 2014.(In Chinese). PubMed/NCBI

6 

Ambrosini G, Adida C and Altieri DC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 3:917–921. 1997. View Article : Google Scholar : PubMed/NCBI

7 

Fenstermaker RA, Figel SA, Qiu JX, Barone TA, Dharma SS, Winograd EK, Galbo PM, Wiltsie LM and Ciesielski MJ: Survivin monoclonal antibodies detect survivin cell surface expression and inhibit tumor growth in vivo. Clin Cancer Res. 24:2642–2652. 2018. View Article : Google Scholar : PubMed/NCBI

8 

Altieri DC: Survivin in apoptosis control and cell cycle regulation in cancer. Prog Cell Cycle Res. 5:447–452. 2003.PubMed/NCBI

9 

Dohi T, Okada K, Xia F, Wilford CE, Samuel T, Welsh K, Marusawa H, Zou H, Armstrong R, Matsuzawa S, et al: An IAP-IAP complex inhibits apoptosis. J Biol Chem. 279:34087–34090. 2004. View Article : Google Scholar : PubMed/NCBI

10 

Kapiris I, Nastos K, Karakatsanis A, Theodosopoulos T, Karandrea D, Pafiti AK and Contis J: Survivin expression in hepatocellular carcinoma. Correlation with clinicopathological characteristics and overall survival. J BUON. 24:1934–1942. 2019.PubMed/NCBI

11 

Chu YJ, Ma WD, Thome R, Ping JD, Liu FZ, Wang MR, Zhang ML, Zhang GX and Zhu L: Matrine inhibits CNS autoimmunity through an IFN-β-dependent mechanism. Front Immunol. 11:5695302020. View Article : Google Scholar : PubMed/NCBI

12 

Wang L, Gao C, Yao SK and Xie B: Blocking autophagic flux enhances matrine-induced apoptosis in human hepatoma cells. Int J Mol Sci. 14:23212–23230. 2013. View Article : Google Scholar : PubMed/NCBI

13 

Zheng YM, Li X, Zhao HY and Zhao JY: Effect of matrine and oxymatrine on proliferation and expression of Stat3 and Stat5 in SMMC-7721 cell line. Zhongguo Zhong Yao Za Zhi. 33:2234–2237. 2008.(In Chinese). PubMed/NCBI

14 

Qin XG, Hua Z, Shuang W, Wang YH and Cui YD: Effects of matrine on HepG2 cell proliferation and expression of tumor relevant proteins in vitro. Pharm Biol. 48:275–281. 2010. View Article : Google Scholar : PubMed/NCBI

15 

Wu LC, Liu SB, Wei JR, Li D, Liu X, Wang JY and Wang LS: Synthesis and biological evaluation of matrine derivatives as anti-hepatocellular cancer agents. Bioorg Med Chem Lett. 26:4267–4271. 2016. View Article : Google Scholar : PubMed/NCBI

16 

Hu J, Huang ZS, Hu GY and Huang MY: Oxymatrine combined with cisplatin enhances expression of vascular endothelial growth factor and CD31 in subcutaneous Xenografts of human hepatocellular carcinoma in nude mice. J Third Military Med Univ. 40:136–140. 2018.

17 

Li X, Liang T, Chen SS, Wang M, Wang R, Li K, Wang JC, Xu CW, Du N, Qin S and Ren H: Matrine suppression of self-renewal was dependent on regulation of LIN28A/Let-7 pathway in breast cancer stem cells. J Cell Biochem. 121:2139–2149. 2020. View Article : Google Scholar : PubMed/NCBI

18 

Pu JT, Tang XJ, Zhuang X, Hu Z, He KM, Wu YF and Dai TY: Matrine induces apoptosis via targeting CCR7 and enhances the effect of anticancer drugs in non-small cell lung cancer in vitro. Innate Immun. 24:394–399. 2018. View Article : Google Scholar : PubMed/NCBI

19 

Gu YY, Chen MH, May BH, Liao XZ, Liu JH, Tao LT, Man-Yuen Sze D, Zhang AL and Mo SL: Matrine induces apoptosis in multiple colorectal cancer cell lines in vitro and inhibits tumour growth with minimum side effects in vivo via Bcl-2 and caspase-3. Phytomedicine. 51:214–225. 2018. View Article : Google Scholar : PubMed/NCBI

20 

Li Q, Xu J, He Z, Wen X, Wang F, Zhang P, Li J, Song B, Wang Q, Li R and Huang H: The effects of matrine in combination with docetaxel on castration-resistant (Androgen-Independent) prostate cancer. Cancer Manag Res. 11:10125–10133. 2019. View Article : Google Scholar : PubMed/NCBI

21 

Brognaro E: ‘The development tumor model’ to study and monitor the entire progression of both primary and metastatic tumors. Tumour Biol. 35:2219–2230. 2014. View Article : Google Scholar : PubMed/NCBI

22 

Suzuki A, Hayashida M, Ito T, Kawano H, Nakano T, Miura M, Akahane K and Shiraki K: Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16INK4a and Cdk2/cyclin E complex activation. Oncogene. 19:3225–3234. 2000. View Article : Google Scholar : PubMed/NCBI

23 

Suzuki A, Ito T, Kawano H, Hayashida M, Hayasaki Y, Tsutomi Y, Akahane K, Nakano T, Miura M and Shiraki K: Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death. Oncogene. 19:1346–1353. 2000. View Article : Google Scholar : PubMed/NCBI

24 

Ikeguchi M, Ueda T, Sakatani T, Hirooka Y and Kaibara N: Expression of survivin messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma. Diagn Mol Pathol. 11:33–40. 2002. View Article : Google Scholar : PubMed/NCBI

25 

Zhang R, Ma L, Zheng M, Ren J, Wang T, Meng Y, Zhao J, Jia L, Yao L, Han H, et al: Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice. Cancer Gene Ther. 17:275–288. 2010. View Article : Google Scholar : PubMed/NCBI

26 

Dai DJ, Lu CD, Lai RY, Guo JM, Meng H, Chen WS and Gu J: Survivin antisense compound inhibits proliferation and promotes apoptosis in liver cancer cells. World J Gastroenterol. 11:193–199. 2005. View Article : Google Scholar : PubMed/NCBI

27 

Thornberry NA and Lazebnik Y: Caspases: Enemies within. Science. 281:1312–1316. 1998. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Hu G, Cao C, Deng Z, Li J, Zhou X, Huang Z and Cen C: Effects of matrine in combination with cisplatin on liver cancer. Oncol Lett 21: 66, 2021.
APA
Hu, G., Cao, C., Deng, Z., Li, J., Zhou, X., Huang, Z., & Cen, C. (2021). Effects of matrine in combination with cisplatin on liver cancer. Oncology Letters, 21, 66. https://doi.org/10.3892/ol.2020.12327
MLA
Hu, G., Cao, C., Deng, Z., Li, J., Zhou, X., Huang, Z., Cen, C."Effects of matrine in combination with cisplatin on liver cancer". Oncology Letters 21.1 (2021): 66.
Chicago
Hu, G., Cao, C., Deng, Z., Li, J., Zhou, X., Huang, Z., Cen, C."Effects of matrine in combination with cisplatin on liver cancer". Oncology Letters 21, no. 1 (2021): 66. https://doi.org/10.3892/ol.2020.12327
Copy and paste a formatted citation
x
Spandidos Publications style
Hu G, Cao C, Deng Z, Li J, Zhou X, Huang Z and Cen C: Effects of matrine in combination with cisplatin on liver cancer. Oncol Lett 21: 66, 2021.
APA
Hu, G., Cao, C., Deng, Z., Li, J., Zhou, X., Huang, Z., & Cen, C. (2021). Effects of matrine in combination with cisplatin on liver cancer. Oncology Letters, 21, 66. https://doi.org/10.3892/ol.2020.12327
MLA
Hu, G., Cao, C., Deng, Z., Li, J., Zhou, X., Huang, Z., Cen, C."Effects of matrine in combination with cisplatin on liver cancer". Oncology Letters 21.1 (2021): 66.
Chicago
Hu, G., Cao, C., Deng, Z., Li, J., Zhou, X., Huang, Z., Cen, C."Effects of matrine in combination with cisplatin on liver cancer". Oncology Letters 21, no. 1 (2021): 66. https://doi.org/10.3892/ol.2020.12327
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team